Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002249 · ClinicalTrials.gov registry record · Phase 1
A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection
A Phase 1 study, sponsored by R W Johnson Pharmaceutical Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00002249: Completed Phase 1 study, sponsored by R W Johnson Pharmaceutical Research Institute.
NCT00002249 is a Phase 1 study that has completed, run by R W Johnson Pharmaceutical Research Institute. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002249, a Phase 1 study, has completed, sponsored by R W Johnson Pharmaceutical Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
To determine the safety and pharmacokinetics of L-ofloxacin (RWJ 25213) in patients with HIV infection.
Interventions
- DRUG Levofloxacin
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00002249 record still lists
NCT00002249 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Levofloxacin is the first listed.
NCT00002249 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002249 about?
NCT00002249 is a clinical study titled "A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection". To determine the safety and pharmacokinetics of L-ofloxacin (RWJ 25213) in patients with HIV infection.
What is the current status of trial NCT00002249?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00002249?
The interventions under investigation include: Levofloxacin (DRUG).
Who is sponsoring clinical trial NCT00002249?
This trial is sponsored by R W Johnson Pharmaceutical Research Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.